中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2014年
5期
159-161
,共3页
刘文瑶%王晓娟%邵雷%王红秋
劉文瑤%王曉娟%邵雷%王紅鞦
류문요%왕효연%소뢰%왕홍추
残留卵巢综合征%全子宫切除术%妈富隆%预防
殘留卵巢綜閤徵%全子宮切除術%媽富隆%預防
잔류란소종합정%전자궁절제술%마부륭%예방
Residual ovarian syndrome%Hysterectomy%Marvelon%Prevention
目的:研究子宫全切除术后,由于手术方式不同、手术难易程度不同和术后是否服用“妈富隆”,残留卵巢综合征(ROS)的发生情况。方法(1)术后未服妈富隆,不同术式与残留卵巢综合征发生情况的研究。(2)术后均用三个周期妈富隆,不同术式术后服用妈富隆与残留卵巢综合征发生情况的研究。(3)相同术式术后服用与不服用妈富隆发生残留卵巢综合征情况的研究。结果简单子宫切除术、阴式子宫切除术组未服妈富隆ROS发生率高于服用妈富隆组,但二组差异无统计学意义。困难子宫切除术未服妈富隆ROS发生率高于服用妈富隆组,二组差异有统计学意义,故术后服妈富隆能很好的预防残留卵巢综合征发生,尤其行困难子宫切除术患者,术后须服用妈富隆预防残留卵巢综合征(ROS)发生。行单子宫切除术和阴式子宫切除术患者,术后也应用妈富隆预防残留卵巢综合征的发生。结论妈富隆对预防残留卵巢综合征发生有明显效果。
目的:研究子宮全切除術後,由于手術方式不同、手術難易程度不同和術後是否服用“媽富隆”,殘留卵巢綜閤徵(ROS)的髮生情況。方法(1)術後未服媽富隆,不同術式與殘留卵巢綜閤徵髮生情況的研究。(2)術後均用三箇週期媽富隆,不同術式術後服用媽富隆與殘留卵巢綜閤徵髮生情況的研究。(3)相同術式術後服用與不服用媽富隆髮生殘留卵巢綜閤徵情況的研究。結果簡單子宮切除術、陰式子宮切除術組未服媽富隆ROS髮生率高于服用媽富隆組,但二組差異無統計學意義。睏難子宮切除術未服媽富隆ROS髮生率高于服用媽富隆組,二組差異有統計學意義,故術後服媽富隆能很好的預防殘留卵巢綜閤徵髮生,尤其行睏難子宮切除術患者,術後鬚服用媽富隆預防殘留卵巢綜閤徵(ROS)髮生。行單子宮切除術和陰式子宮切除術患者,術後也應用媽富隆預防殘留卵巢綜閤徵的髮生。結論媽富隆對預防殘留卵巢綜閤徵髮生有明顯效果。
목적:연구자궁전절제술후,유우수술방식불동、수술난역정도불동화술후시부복용“마부륭”,잔류란소종합정(ROS)적발생정황。방법(1)술후미복마부륭,불동술식여잔류란소종합정발생정황적연구。(2)술후균용삼개주기마부륭,불동술식술후복용마부륭여잔류란소종합정발생정황적연구。(3)상동술식술후복용여불복용마부륭발생잔류란소종합정정황적연구。결과간단자궁절제술、음식자궁절제술조미복마부륭ROS발생솔고우복용마부륭조,단이조차이무통계학의의。곤난자궁절제술미복마부륭ROS발생솔고우복용마부륭조,이조차이유통계학의의,고술후복마부륭능흔호적예방잔류란소종합정발생,우기행곤난자궁절제술환자,술후수복용마부륭예방잔류란소종합정(ROS)발생。행단자궁절제술화음식자궁절제술환자,술후야응용마부륭예방잔류란소종합정적발생。결론마부륭대예방잔류란소종합정발생유명현효과。
Objective To study the relationship between complete resection of uterine and residual ovarian syndrome and the prophylactic effect of taking marvelon after operation. Methods (1)Patients weren't given marvelon after operation, and the relationship between different operative methods and residual ovarian syndrome was observed. (2)Patients were given three cycles marvelon after operation. The relationship between different operative methods and residual ovarian syndrome was observed. (3)After the same operation, the relationship between residual ovarian syndrome and taking marvelon was observed. Results The ROS incidence rates of patients without taking marvelon in simple hysterectomy group and vaginal hysterectomy group were higher than that of taking Marvelon group, but there was no significant difference between the two groups. The ROS incidence rate of patients without taking marvelon was higher than that of taking marvelon patients in difficult hysterectomy group, and difference was significant. Marvelon can prevent ROS occurs for hysterectomy patients, especially difficult hysterectomy patients. Conclusion Marvelon have obvious effect for preventing residual ovarian syndrome.